| For: | Lai YC, Yang JC, Huang SH. Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. World J Gastroenterol 2004; 10(7): 991-994 [PMID: 15052680 DOI: 10.3748/wjg.v10.i7.991] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i7/991.htm |
| Number | Citing Articles |
| 1 |
Sergey I Pimanov, Elena V Makarenko, Alla V Voropaeva, Maya E Matveenko, Eugen V Voropaev. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. Journal of Gastroenterology and Hepatology 2008; 23(11) doi: 10.1111/j.1440-1746.2007.04983.x
|
| 2 |
Masayuki Tatemichi, Shizuka Sasazuki, Manami Inoue, Shoichiro Tsugane. Clinical Significance of IgG Antibody Titer against Helicobacter pylori. Helicobacter 2009; 14(3) doi: 10.1111/j.1523-5378.2009.00681.x
|
| 3 |
J.P. Gisbert, J.M. Pajares. 13C-urea breath test in the management of Helicobacter pylori infection. Digestive and Liver Disease 2005; 37(12) doi: 10.1016/j.dld.2005.09.006
|
| 4 |
Javier P. Gisbert, Xavier Calvet, Anthony O'Connor, Francis Mégraud, Colm A. O'Morain. Sequential Therapy for Helicobacter pylori Eradication. Journal of Clinical Gastroenterology 2010; 44(5) doi: 10.1097/MCG.0b013e3181c8a1a3
|
| 5 |
Efrat Broide, Haim Shirin. Evaluation of Exalenz Bioscience’s BreathID forHelicobacter pyloridetection. Expert Review of Molecular Diagnostics 2015; 15(3) doi: 10.1586/14737159.2015.982537
|
| 6 |
Bong-Ku Kang, Sung Min Park, Byung Wook Kim. New Therapeutic Strategies againstHelicobacter pylori. The Korean Journal of Gastroenterology 2014; 63(3) doi: 10.4166/kjg.2014.63.3.146
|
| 7 |
Jong Yeul Lee, Ji Yong Ahn, Il Ju Choi. Historical Perspective ofHelicobacter pyloriTreatment in Korea. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(4) doi: 10.7704/kjhugr.2015.15.4.211
|
| 8 |
Angelo Zullo, Vincenzo De Francesco, Cesare Hassan, Sergio Morini, Dino Vaira. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007; 56(10) doi: 10.1136/gut.2007.125658
|
| 9 |
Muhammad Miftahussurur, Yoshio Yamaoka. Diagnostic Methods ofHelicobacter pyloriInfection for Epidemiological Studies: Critical Importance of Indirect Test Validation. BioMed Research International 2016; 2016 doi: 10.1155/2016/4819423
|
| 10 |
Toshihiro Nishizawa, Hidekazu Suzuki, Masahiko Takahashi, Masayuki Suzuki, Toshifumi Hibi. Delay of second‐line eradication therapy for Helicobacter pylori can increase eradication failure. Journal of Gastroenterology and Hepatology 2013; 28(10) doi: 10.1111/jgh.12281
|
| 11 |
Jyh-Chin Yang, Chun-Jung Lin. CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy ofHelicobacter pyloriinfection. Expert Opinion on Drug Metabolism & Toxicology 2010; 6(1) doi: 10.1517/17425250903386251
|
| 12 |
Karen A. Krogfelt, Philippe Lehours, Francis Mégraud. Diagnosis of Helicobacter pylori Infection. Helicobacter 2005; 10(s1) doi: 10.1111/j.1523-5378.2005.00341.x
|
| 13 |
Francis Mégraud, Philippe Lehours. Helicobacter pyloriDetection and Antimicrobial Susceptibility Testing. Clinical Microbiology Reviews 2007; 20(2) doi: 10.1128/CMR.00033-06
|
| 14 |
Angelo Zullo, Carola Severi, Lucy Vannella, Cesare Hassan, Andrea Sbrozzi-Vanni, Bruno Annibale. Role of gastritis pattern on Helicobacter pylori eradication. Internal and Emergency Medicine 2012; 7(6) doi: 10.1007/s11739-011-0730-4
|
| 15 |
|
| 16 |
Ki Bang Kim, Yong Sik Kim. Recent Trends ofHelicobacter pyloriEradication Therapy: Focusing on First Line Treatment. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2014; 14(4) doi: 10.7704/kjhugr.2014.14.4.237
|
| 17 |
Faezeh Kiani, Sara Khademolhosseini, Mobina Fathi, Arian Tavasol, Jasem Mohammadi, Majid Dousti, Jalal Eshagh Hoseini. Standard Triple Therapy as a Remedy for Treatment of Helicobacter pylori
Infection: A Systematic Review and Meta-analysis of Randomized Clinical
Trials. Current Reviews in Clinical and Experimental Pharmacology 2023; 18(2) doi: 10.2174/2772432817666220317152544
|
| 18 |
György M. Buzás, Ilona Széles. Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection. Journal of Gastroenterology 2008; 43(2) doi: 10.1007/s00535-007-2135-8
|
| 19 |
|
| 20 |
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert, Javier P Gisbert. Cochrane Database of Systematic Reviews. 2011; doi: 10.1002/14651858.CD009034
|
| 21 |
V. De Francesco, A. Zullo, E. Ierardi, F. Giorgio, F. Perna, C. Hassan, S. Morini, C. Panella, D. Vaira. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. Journal of Antimicrobial Chemotherapy 2010; 65(2) doi: 10.1093/jac/dkp445
|
| 22 |
|
| 23 |
J.P. Gisbert, D. Olivares, I. Jimenez, J.M. Pajares. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?. Digestive and Liver Disease 2006; 38(4) doi: 10.1016/j.dld.2005.10.022
|
| 24 |
Olga P. Nyssen, Belén Martínez, Francis Mégraud, Vincenzo Savarino, Carlo A. Fallone, Franco Bazzoli, Javier P. Gisbert. Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update. Antibiotics 2024; 13(2) doi: 10.3390/antibiotics13020136
|
| 25 |
J. P. Gisbert, X. Calvet. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. Alimentary Pharmacology & Therapeutics 2011; 34(6) doi: 10.1111/j.1365-2036.2011.04770.x
|
| 26 |
|
| 27 |
Javier P Gisbert, Xavier Calvet, JP Anthony O'Connor, Francis Mégraud, Colm A O'Morain. The sequential therapy regimen forHelicobacter pylorieradication. Expert Opinion on Pharmacotherapy 2010; 11(6) doi: 10.1517/14656561003657152
|
| 28 |
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo A Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert. Sequential versus standard triple first-line therapy forHelicobacter pylorieradication. Cochrane Database of Systematic Reviews 2016; 2016(6) doi: 10.1002/14651858.CD009034.pub2
|
| 29 |
Kee Don Choi. Current Trends ofHelicobacter pyloriEradication in Korea. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(3) doi: 10.7704/kjhugr.2015.15.3.147
|
| 30 |
Su Young Kim, Dong Kyun Park, Kwang An Kwon, Kyoung Oh Kim, Yoon Jae Kim, Jun Won Chung. Ten Day Concomitant Therapy Is Superior to Ten Day Sequential Therapy forHelicobacter pyloriEradication. The Korean Journal of Gastroenterology 2014; 64(5) doi: 10.4166/kjg.2014.64.5.260
|
| 31 |
Y. S. Kim, S. J. Kim, J. H. Yoon, K. T. Suk, J. B. Kim, D. J. Kim, D. Y. Kim, H. J. Min, S. H. Park, W. G. Shin, K. H. Kim, H. Y. Kim, G. H. Baik. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Alimentary Pharmacology & Therapeutics 2011; 34(9) doi: 10.1111/j.1365-2036.2011.04843.x
|
| 32 |
Angelo Zullo, Vincenzo De Francesco, Cesare Hassan. Predicting Helicobacter pylori Eradication. Journal of Clinical Gastroenterology 2012; 46(4) doi: 10.1097/MCG.0b013e318247177e
|
| 33 |
Jong In Kim, Byung-Wook Kim. Sequential Therapy ofHelicobacter pyloriInfection. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2011; 11(2) doi: 10.7704/kjhugr.2011.11.2.103
|
| 34 |
David Y Graham, Lori Fischbach.
Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010; 59(8) doi: 10.1136/gut.2009.192757
|
| 35 |
Angelo Zullo, Federico Perna, Chiara Ricci, Cesare Hassan, Andrea Tampieri, Vincenzo De Francesco, Sergio Morini, Dino Vaira. 13C-Urea Breath Test Values and Helicobacter pylori Eradication. Digestive Diseases and Sciences 2008; 53(2) doi: 10.1007/s10620-007-9893-2
|